|
|
|
Insider
Information: |
Elkins David V |
Relationship: |
Director |
City: |
Franklin Lakes |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
196,756 |
|
Indirect Shares
|
216 |
|
|
Direct
Value |
$8,088,995 |
|
|
Indirect Value
|
$8,875 |
|
|
Total
Shares |
196,972 |
|
|
Total
Value |
$8,097,871 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
5.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Becton Dickinson & Co |
BDX |
Executive VP and CFO |
2012-11-09 |
0 |
|
0 |
Premium* |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
Bristol-Myers Squibb Co |
BMY |
EVP, Chief Financial O... |
2024-03-10 |
194,968 |
2024-03-10 |
216 |
Premium* |
|
Tapestry Inc |
TPR |
Director |
2024-02-29 |
1,788 |
2024-02-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-03-10 |
4 |
D |
$60.93 |
$263,766 |
D/D |
(4,329) |
87,032 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-08-01 |
4 |
D |
$67.87 |
$1,610,962 |
D/D |
(23,736) |
109,699 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,403 |
133,435 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-08-12 |
4 |
OE |
$48.49 |
$3,394,300 |
D/D |
70,000 |
139,699 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-08-12 |
4 |
S |
$66.88 |
$6,674,497 |
D/D |
(99,691) |
80,008 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,792 |
88,800 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-12-02 |
4 |
D |
$55.41 |
$249,234 |
D/D |
(4,498) |
84,302 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-12-31 |
4 |
D |
$62.35 |
$1,511,738 |
D/D |
(24,246) |
107,457 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,401 |
131,703 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,577 |
132,034 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-03-01 |
4 |
D |
$68.63 |
$712,448 |
D/D |
(10,381) |
121,653 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,067 |
134,133 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,962 |
135,035 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-03-10 |
4 |
D |
$68.42 |
$630,969 |
D/D |
(9,222) |
130,460 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-09-13 |
4 |
S |
$71.29 |
$9,551,167 |
D/D |
(133,951) |
119,786 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-09-13 |
4 |
OE |
$48.49 |
$5,977,702 |
D/D |
123,277 |
223,737 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,792 |
128,578 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2022-12-02 |
4 |
D |
$81.13 |
$364,923 |
D/D |
(4,498) |
124,080 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
71,871 |
185,308 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2023-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
8,930 |
191,187 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2023-03-10 |
4 |
D |
$65.71 |
$2,715,860 |
D/D |
(41,331) |
163,550 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2023-12-02 |
4 |
D |
$50.10 |
$186,873 |
D/D |
(3,730) |
168,612 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2023-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,792 |
172,342 |
0 |
- |
|
TPR |
Tapestry Inc |
Director |
|
2024-02-29 |
4 |
A |
$47.53 |
$84,984 |
D/D |
1,788 |
1,788 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Financial Officer |
|
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
64,326 |
225,111 |
0 |
- |
|
52 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|